Purchase of TAS asssays
Past New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $10,000 to $25,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Points of contact
-
- HFP Acquisition Liaison hfpacquisitions@fda.hhs.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration (FDA) is seeking to procure targeted amplicon sequencing (TAS) assays to identify and characterize different strains of Salmonella and Cronobacter contaminating powdered infant formula. This new requirement is classified under Analytical Laboratory Instrument Manufacturing (NAICS 334516) and carries no set-aside designation. The solicitation is forecasted to be released on May 1, 2026, with an estimated award date of May 1, 2026.
The estimated contract award value ranges from $10,000 to $25,000. While specific quantities and detailed performance timelines are not provided in the forecast, this procurement is being managed by the FDA's acquisition team. Interested vendors should direct inquiries to the FDA Acquisition Liaison at hfpacquisitions@fda.hhs.gov for additional information regarding this opportunity.
Forecast text
Request to purchase targeted amplicon sequencing (TAS) assays to understand what different kinds of Salmonella and Cronobacter are present and contaminating powdered infant formula
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast